Clinical trials are actively studying new treatments for amyloidosis, including innovative approaches like gene therapy and antibodies targeting amyloid proteins. Some trials are also investigating CAR T-cell therapy, which engineers immune cells to treat the condition.
If you're interested in participating in a clinical Show Full Answer
Clinical trials are actively studying new treatments for amyloidosis, including innovative approaches like gene therapy and antibodies targeting amyloid proteins. Some trials are also investigating CAR T-cell therapy, which engineers immune cells to treat the condition.
If you're interested in participating in a clinical trial, it's recommended to discuss this option with your healthcare provider. They can help determine if you're eligible and explain the potential benefits and risks involved. Gene-silencing therapies have shown promising results in clinical trials, particularly when started early. These treatments work by targeting the root cause of the disease and stopping the body from making abnormal TTR protein. They use two main approaches:
• RNA interference (RNAi)
• Antisense oligonucleotides (ASOs)
Recent trials have led to several FDA-approved treatments, demonstrating the value of clinical research in advancing treatment options for people with amyloidosis.
October 3, 2025
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
